NasdaqGM - Nasdaq Real Time Price USD
Gain Therapeutics, Inc. (GANX)
1.8500
0.0000
(0.00%)
At close: April 23 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.3M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ISLAM KHALID Officer and Director | Purchase at price 1.00 per share. | Direct | 49,940 | Aug 9, 2024 |
| MACK GENE C Chief Executive Officer | Purchase at price 1.01 per share. | Direct | 14,544 | Aug 9, 2024 |
| RICHMAN ERIC I. Director | Purchase at price 1.21 - 1.23 per share. | Direct | 20,670 | Jul 1, 2024 |
| RILEY JEFFREY SCOTT Director | Purchase at price 3.86 per share. | Direct | 115,770 | Mar 28, 2024 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Mar 26, 2024 |
| ALDER MATTHIAS Chief Executive Officer | Sale at price 2.46 per share. | Direct | 507 | Dec 21, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Dec 20, 2023 |
| ALDER MATTHIAS Chief Executive Officer | Sale at price 2.50 per share. | Direct | 4,550 | Dec 7, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Sep 29, 2023 |
| RICHMAN ERIC I. Director | -- | Direct | -- | Sep 20, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Sep 20, 2023 |
| ALDER MATTHIAS Chief Executive Officer | -- | Direct | -- | Jun 30, 2023 |
Related Tickers
COYA Coya Therapeutics, Inc.
6.56
-1.20%
INMB INmune Bio, Inc.
8.24
+5.10%
PYPD PolyPid Ltd.
2.7500
+0.36%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
FENC Fennec Pharmaceuticals Inc.
5.65
+3.86%
AVIR Atea Pharmaceuticals, Inc.
2.8500
-0.70%
CRVS Corvus Pharmaceuticals, Inc.
3.5200
+5.71%
ERAS Erasca, Inc.
1.4200
+2.90%
TERN Terns Pharmaceuticals, Inc.
2.8800
+2.86%
ARTV Artiva Biotherapeutics, Inc.
2.4500
0.00%